EdgarLookup

MOSAIC CO — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MOSAIC CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
4.5%
Profit Margin
Net income ÷ revenue
2.2%
Return on Assets
Net income ÷ assets
+8.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.05B Feb 27, 2026
FY2025 Dec 31, 2024 $11.12B Feb 27, 2026
FY2025 Dec 31, 2023 $13.70B Feb 27, 2026
FY2024 Dec 31, 2022 $19.13B Mar 3, 2025
FY2023 Dec 31, 2021 $12.36B Feb 22, 2024
FY2022 Dec 31, 2020 $8.68B Feb 23, 2023
FY2021 Dec 31, 2019 $8.91B Feb 23, 2022
FY2020 Dec 31, 2018 $9.59B Feb 22, 2021

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.05B Feb 27, 2026
FY2025 Dec 31, 2024 $11.12B Feb 27, 2026
FY2025 Dec 31, 2023 $13.70B Feb 27, 2026
FY2024 Dec 31, 2022 $19.13B Mar 3, 2025
FY2023 Dec 31, 2021 $12.36B Feb 22, 2024
FY2022 Dec 31, 2020 $8.68B Feb 23, 2023
FY2021 Dec 31, 2019 $8.91B Feb 23, 2022
FY2020 Dec 31, 2018 $9.59B Feb 22, 2021

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.90B Feb 27, 2026
FY2025 Dec 31, 2024 $1.51B Feb 27, 2026
FY2025 Dec 31, 2023 $2.21B Feb 27, 2026
FY2024 Dec 31, 2022 $5.76B Mar 3, 2025
FY2023 Dec 31, 2021 $3.20B Feb 22, 2024
FY2022 Dec 31, 2020 $1.06B Feb 23, 2023
FY2021 Dec 31, 2019 $897.30M Feb 23, 2022
FY2020 Dec 31, 2018 $1.50B Feb 22, 2021
FY2019 Dec 31, 2017 $842.80M Feb 20, 2020
FY2018 Dec 31, 2016 $810.00M Mar 13, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $540.70M Feb 27, 2026
FY2025 Dec 31, 2024 $174.90M Feb 27, 2026
FY2025 Dec 31, 2023 $1.16B Feb 27, 2026
FY2024 Dec 31, 2022 $3.58B Mar 3, 2025
FY2023 Dec 31, 2021 $1.63B Feb 22, 2024
FY2022 Dec 31, 2020 $666.10M Feb 23, 2023
FY2021 Dec 31, 2019 ($1.07B) Feb 23, 2022
FY2020 Dec 31, 2018 $470.00M Feb 22, 2021
FY2019 Dec 31, 2017 ($107.20M) Feb 20, 2020
FY2018 Dec 31, 2016 $297.80M Mar 13, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $821.50M Feb 27, 2026
FY2025 Dec 31, 2024 $621.50M Feb 27, 2026
FY2025 Dec 31, 2023 $1.34B Feb 27, 2026
FY2024 Dec 31, 2022 $4.79B Mar 3, 2025
FY2023 Dec 31, 2021 $2.47B Feb 22, 2024
FY2022 Dec 31, 2020 $412.90M Feb 23, 2023
FY2021 Dec 31, 2019 ($1.09B) Feb 23, 2022
FY2020 Dec 31, 2018 $928.30M Feb 22, 2021
FY2019 Dec 31, 2017 $465.70M Feb 20, 2020
FY2018 Dec 31, 2016 $319.00M Mar 13, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $533.90M Feb 27, 2026
FY2025 Dec 31, 2024 $496.90M Feb 27, 2026
FY2025 Dec 31, 2023 $500.50M Feb 27, 2026
FY2024 Dec 31, 2022 $498.00M Mar 3, 2025
FY2023 Dec 31, 2021 $430.50M Feb 22, 2024
FY2022 Dec 31, 2020 $371.50M Feb 23, 2023
FY2021 Dec 31, 2019 $354.10M Feb 23, 2022
FY2020 Dec 31, 2018 $341.10M Feb 22, 2021
FY2019 Dec 31, 2017 $301.30M Feb 20, 2020
FY2018 Dec 31, 2016 $304.20M Mar 13, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $824.80M Feb 27, 2026
FY2025 Dec 31, 2024 $1.30B Feb 27, 2026
FY2025 Dec 31, 2023 $2.41B Feb 27, 2026
FY2024 Dec 31, 2022 $3.94B Mar 3, 2025
FY2023 Dec 31, 2021 $2.19B Feb 22, 2024
FY2022 Dec 31, 2020 $1.58B Feb 23, 2023
FY2021 Dec 31, 2019 $1.10B Feb 23, 2022
FY2020 Dec 31, 2018 $1.41B Feb 22, 2021
FY2019 Dec 31, 2017 $935.50M Feb 20, 2020
FY2018 Dec 31, 2016 $1.26B Mar 13, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.36B Feb 27, 2026
FY2025 Dec 31, 2024 $1.25B Feb 27, 2026
FY2025 Dec 31, 2023 $1.40B Feb 27, 2026
FY2024 Dec 31, 2022 $1.25B Mar 3, 2025
FY2023 Dec 31, 2021 $1.29B Feb 22, 2024
FY2022 Dec 31, 2020 $1.17B Feb 23, 2023
FY2021 Dec 31, 2019 $1.27B Feb 23, 2022
FY2020 Dec 31, 2018 $954.50M Feb 22, 2021
FY2019 Dec 31, 2017 $820.10M Feb 20, 2020
FY2018 Dec 31, 2016 $843.10M Mar 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $24.48B Feb 27, 2026
FY2025 Dec 31, 2024 $22.92B Feb 27, 2026
FY2025 Dec 31, 2023 $23.03B Feb 27, 2026
FY2024 Dec 31, 2022 $23.39B Mar 3, 2025
FY2023 Dec 31, 2021 $22.04B Feb 22, 2024
FY2022 Dec 31, 2020 $19.79B Feb 23, 2023
FY2021 Dec 31, 2019 $19.30B Feb 23, 2022
FY2020 Dec 31, 2018 $20.12B Feb 22, 2021
FY2019 Dec 31, 2017 $18.63B Feb 20, 2020
FY2018 Dec 31, 2016 $16.84B Mar 13, 2019

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.08B Feb 27, 2026
FY2025 Dec 31, 2024 $11.48B Feb 27, 2026
FY2024 Dec 31, 2023 $12.29B Mar 3, 2025
FY2023 Dec 31, 2022 $12.05B Feb 22, 2024
FY2022 Dec 31, 2021 $10.60B Feb 23, 2023
FY2021 Dec 31, 2020 $9.58B Feb 23, 2022
FY2020 Dec 31, 2019 $9.19B Feb 22, 2021
FY2019 Dec 31, 2018 $10.40B Feb 20, 2020
FY2018 Dec 31, 2017 $9.62B Mar 13, 2019
FY2017 Dec 31, 2016 $9.58B Feb 21, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.01B Feb 27, 2026
FY2025 Dec 31, 2024 $1.06B Feb 27, 2026
FY2025 Dec 31, 2023 $1.14B Feb 27, 2026
FY2024 Dec 31, 2022 $1.12B Mar 3, 2025
FY2023 Dec 31, 2021 $1.17B Feb 22, 2024
FY2022 Dec 31, 2020 $1.17B Feb 23, 2023
FY2021 Dec 31, 2019 $1.16B Feb 23, 2022
FY2020 Dec 31, 2018 $1.71B Feb 22, 2021
FY2019 Dec 31, 2017 $1.69B Feb 20, 2020
FY2018 Dec 31, 2016 $1.63B Mar 13, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.18B Feb 27, 2026
FY2025 Dec 31, 2024 $13.93B Feb 27, 2026
FY2024 Dec 31, 2023 $14.24B Mar 3, 2025
FY2023 Dec 31, 2022 $14.20B Feb 22, 2024
FY2022 Dec 31, 2021 $12.01B Feb 23, 2023
FY2021 Dec 31, 2020 $10.51B Feb 23, 2022
FY2020 Dec 31, 2019 $9.92B Feb 22, 2021
FY2019 Dec 31, 2018 $11.06B Feb 20, 2020
FY2019 Jan 1, 2018 $10.63B Feb 20, 2020
FY2019 Dec 31, 2017 $10.63B Feb 20, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $276.60M Feb 27, 2026
FY2025 Dec 31, 2024 $272.80M Feb 27, 2026
FY2025 Dec 31, 2023 $348.80M Feb 27, 2026
FY2024 Dec 31, 2022 $735.40M Mar 3, 2025
FY2023 Dec 31, 2021 $769.50M Feb 22, 2024
FY2022 Dec 31, 2020 $574.00M Feb 23, 2023
FY2021 Dec 31, 2019 $519.10M Feb 23, 2022
FY2020 Dec 31, 2018 $847.70M Feb 22, 2021
FY2019 Dec 31, 2017 $2.15B Feb 20, 2020
FY2018 Dec 31, 2016 $673.10M Mar 13, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2015 $3.83B Feb 19, 2016
FY2015 Dec 31, 2014 $3.82B Feb 19, 2016
FY2014 Dec 31, 2013 $3.01B Feb 17, 2015
FY2013 May 31, 2013 $1.01B Jul 17, 2013
FY2013 May 31, 2012 $1.01B Jul 17, 2013
FY2012 May 31, 2011 $809.30M Jul 31, 2012
FY2011 May 31, 2010 $1.26B Jul 19, 2011

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2025 Dec 31, 2023 3 Feb 27, 2026
FY2024 Dec 31, 2022 10 Mar 3, 2025
FY2023 Dec 31, 2021 4 Feb 22, 2024
FY2022 Dec 31, 2020 1 Feb 23, 2023
FY2021 Dec 31, 2019 (2) Feb 23, 2022
FY2020 Dec 31, 2018 1 Feb 22, 2021
FY2019 Dec 31, 2017 0 Feb 20, 2020
FY2018 Dec 31, 2016 0 Mar 13, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2025 Dec 31, 2023 3 Feb 27, 2026
FY2024 Dec 31, 2022 10 Mar 3, 2025
FY2023 Dec 31, 2021 4 Feb 22, 2024
FY2022 Dec 31, 2020 1 Feb 23, 2023
FY2021 Dec 31, 2019 (2) Feb 23, 2022
FY2020 Dec 31, 2018 1 Feb 22, 2021
FY2019 Dec 31, 2017 0 Feb 20, 2020
FY2018 Dec 31, 2016 0 Mar 13, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 317.41M Feb 27, 2026
FY2025 Dec 31, 2024 316.93M Feb 27, 2026
FY2024 Dec 31, 2023 324.10M Mar 3, 2025
FY2023 Dec 31, 2022 339.07M Feb 22, 2024
FY2022 Dec 31, 2021 368.73M Feb 23, 2023
FY2021 Dec 31, 2020 378.76M Feb 23, 2022
FY2020 Dec 31, 2019 378.76M Feb 22, 2021
FY2019 Dec 31, 2018 385.47M Feb 20, 2020
FY2018 Dec 31, 2017 351.05M Mar 13, 2019
FY2017 Dec 31, 2016 350.24M Feb 21, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $280.40M Feb 27, 2026
FY2025 Dec 31, 2024 $270.70M Feb 27, 2026
FY2025 Dec 31, 2023 $351.60M Feb 27, 2026
FY2024 Dec 31, 2022 $197.70M Mar 3, 2025
FY2023 Dec 31, 2021 $103.70M Feb 22, 2024
FY2022 Dec 31, 2020 $75.80M Feb 23, 2023
FY2021 Dec 31, 2019 $67.20M Feb 23, 2022
FY2020 Dec 31, 2018 $38.50M Feb 22, 2021
FY2019 Dec 31, 2017 $210.60M Feb 20, 2020
FY2018 Dec 31, 2016 $385.10M Mar 13, 2019